Log In
Print this Print this

Bonalon, Fosamax, alendronate

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionOral formulation of alendronate sodium hydrate
Molecular Target Not available
Mechanism of ActionInhibits bone resorption
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today